Circulatory shock
-
We compared small-volume resuscitation using either normal saline or hypertonic saline (2400 mOsm/liter) during hemorrhagic hypotension. Six unanesthetized sheep were bled to 50 mm Hg mean arterial pressure and maintained for 2 h. During this shock period cardiac output decreased 40-50% of baseline, while total peripheral resistance increased 20-30%. ⋯ Cardiac output recovered to 95% of control immediately after infusion of hypertonic saline, while no significant increase was observed with normal saline. Ten minutes after injection of hypertonic saline, plasma volume increased approximately 360 ml, but with normal saline no increase was observed. We conclude that small-volume injection of hypertonic saline can dramatically improve circulatory function during hemorrhagic shock, as evidenced by expansion of plasma volume, increased cardiac output, and reduced peripheral resistance.
-
Anesthetized spontaneously hypertensive rats (SHR) and normotensive WKY controls were subjected to either a constant pressure (CPH) (constant mean arterial pressure of 35 mmHg) or an incremental volume (IVH) hemorrhage protocol (successive 1-ml blood withdrawals separated by 20 minute compensatory periods). Diameters and pressures were measured in small (400-600 micron) intestinal mesenteric veins before and during hemorrhage. Before hemorrhage, vasodilator suffusion produced a significant venodilation in SHR but not in WKY. ⋯ During CPH, venous pressures in WKY were significantly higher than those in SHR. However, venous pressures in SHR and WKY were not significantly different during CPH with vasodilator suffusion. This study indicates that a decreased reserve capacity for compensatory venoconstriction may contribute to the reduced ability of SHR to tolerate hypotensive stress.
-
Hydroxyethylstarch (HES) is being used increasingly in clinical hemorrhagic shock. Since patients in shock are at high risk of subsequent infection, concern has been voiced about possible adverse effects of HES on the reticuloendothelial system (RES) and host defenses against sepsis. We examined this issue in male albino Holtzman rats given HES or saline (60 ml/kg) i.v. ⋯ In another group of rats, sepsis was produced by cecal ligation and puncture 2 d after HES or saline infusion. The survival rates were 41% and 43%, respectively, in the saline- and HES-treated animals. These studies reveal no deleterious effects of a clinically relevant volume of HES on either RES function or host resistance to sepsis.
-
The pathogenesis of burn shock syndrome involves the production of superoxide radicals which are first generated in the burned skin. They are responsible for an increase in vascular permeability with loss of plasma, which results in hemoconcentration and hypovolemia. The resulting systemic hypoperfusion leads to a generalized production of superoxide radicals and subsequent cellular damage. Prior administration of allopurinol or superoxide dismutase increases the survival rates of mice subjected to burn shock.
-
The effects of temperature on naloxone treatment in canine hemorrhagic shock were examined in 24 dogs hemorrhaged to a mean arterial blood pressure of 35 mm Hg (ambient temperature, 21 degrees C). After two hours of hypotension, the blood reservoir was clamped with no return of shed blood. Dogs were divided into three groups: Control (n = 8) received normal saline (0.5 cc/kg/hr); naloxone-cold (n = 8) and -warm (n = 8) received naloxone (2 mg/kg bolus and 2 mg/kg/hr constant infusion). ⋯ In the warmer dogs, naloxone significantly improved hemodynamic function and myocardial perfusion as indicated by the increased mean arterial pressure, cardiac output, stroke volume, dP/dt, and coronary blood flow. Furthermore, naloxone reduced plasma beta-endorphin levels and corrected the metabolic derangements of shock in this group. Our data indicate hypothermia significantly diminished the beneficial effects of naloxone treatment in canine hemorrhagic shock.